ODTXOdyssey Therapeutics, Inc.
$18.09
$18.09
$15.5652 weeks$28.84
Price
End-of-day closes, not the intraday tick.
The five questions
1 of 5 availableOnly one of the five can be answered for ODTX today. The rest need figures this filer has not published. The tabs above still show whatever data does exist.
- Is the business good?not enough filed
- Is it safe?Watch
- Is the price fair?not enough filed
- Is it growing?not enough filed
- What is the market doing?not enough filed
P/En/a
Market value$853.4M
1 yearn/a
5 yearsn/a
Charts
As reported to the SEC, without any scoring.
Odyssey Therapeutics, Inc. (ODTX) reported revenue of $0 in Q2 2026 (quarter ended Jun 30, 2026), down 100% from the same quarter a year earlier. That came with net loss of $53M. The next results filing is expected around Nov 3, 2026, a quarter after the last one.
What the company said
The company's own words from its current reports to the SEC, newest first
- Sep 9, 2026Corporate Presentation September 2026.Regulation FD disclosure · press release
- Aug 4, 2026Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update.Earnings release · press release
- Jun 23, 2026Corporate Presentation June 2026.Regulation FD disclosure · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Biotechnology
The closest names by size in the same industry